Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Mechanisms of PTEN loss in cancer: It's all about diversity.

Álvarez-Garcia V, Tawil Y, Wise HM, Leslie NR.

Semin Cancer Biol. 2019 Feb 7. pii: S1044-579X(18)30059-2. doi: 10.1016/j.semcancer.2019.02.001. [Epub ahead of print] Review.

PMID:
30738865
2.

A simple and robust real-time qPCR method for the detection of PIK3CA mutations.

Alvarez-Garcia V, Bartos C, Keraite I, Trivedi U, Brennan PM, Kersaudy-Kerhoas M, Gharbi K, Oikonomidou O, Leslie NR.

Sci Rep. 2018 Mar 9;8(1):4290. doi: 10.1038/s41598-018-22473-9.

3.

What is known about melatonin, chemotherapy and altered gene expression in breast cancer.

Martínez-Campa C, Menéndez-Menéndez J, Alonso-González C, González A, Álvarez-García V, Cos S.

Oncol Lett. 2017 Apr;13(4):2003-2014. doi: 10.3892/ol.2017.5712. Epub 2017 Feb 10.

4.

The PTEN protein: cellular localization and post-translational regulation.

Leslie NR, Kriplani N, Hermida MA, Alvarez-Garcia V, Wise HM.

Biochem Soc Trans. 2016 Feb;44(1):273-8. doi: 10.1042/BST20150224. Review.

PMID:
26862215
5.

Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.

Feng X, Szulzewsky F, Yerevanian A, Chen Z, Heinzmann D, Rasmussen RD, Alvarez-Garcia V, Kim Y, Wang B, Tamagno I, Zhou H, Li X, Kettenmann H, Ransohoff RM, Hambardzumyan D.

Oncotarget. 2015 Jun 20;6(17):15077-94.

6.

Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review).

Cos S, Alvarez-García V, González A, Alonso-González C, Martínez-Campa C.

Oncol Lett. 2014 Aug;8(2):487-492. Epub 2014 May 30.

7.

Antiangiogenic effects of melatonin in endothelial cell cultures.

Alvarez-García V, González A, Alonso-González C, Martínez-Campa C, Cos S.

Microvasc Res. 2013 May;87:25-33. doi: 10.1016/j.mvr.2013.02.008. Epub 2013 Mar 6.

PMID:
23473980
8.

Melatonin modulates aromatase activity and expression in endothelial cells.

Alvarez-García V, González A, Martínez-Campa C, Alonso-González C, Cos S.

Oncol Rep. 2013 May;29(5):2058-64. doi: 10.3892/or.2013.2314. Epub 2013 Feb 28.

PMID:
23450505
9.

Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells.

Alvarez-García V, González A, Alonso-González C, Martínez-Campa C, Cos S.

J Pineal Res. 2013 May;54(4):373-80. doi: 10.1111/jpi.12007. Epub 2012 Sep 27.

PMID:
23013414
10.

Melatonin interferes in the desmoplastic reaction in breast cancer by regulating cytokine production.

Alvarez-García V, González A, Alonso-González C, Martínez-Campa C, Cos S.

J Pineal Res. 2012 Apr;52(3):282-90. doi: 10.1111/j.1600-079X.2011.00940.x. Epub 2011 Dec 12.

PMID:
22151118
11.

Melatonin promotes differentiation of 3T3-L1 fibroblasts.

González A, Alvarez-García V, Martínez-Campa C, Alonso-González C, Cos S.

J Pineal Res. 2012 Jan;52(1):12-20. doi: 10.1111/j.1600-079X.2011.00911.x. Epub 2011 Jul 1.

PMID:
21718362
12.

In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin.

González A, Alvarez-García V, Martínez-Campa C, Mediavilla MD, Alonso-González C, Sánchez-Barceló EJ, Cos S.

Curr Cancer Drug Targets. 2010 May;10(3):279-86.

PMID:
20370689
13.

Inhibitory effects of melatonin on sulfatase and 17beta-hydroxysteroid dehydrogenase activity and expression in glioma cells.

González A, Martínez-Campa C, Mediavilla MD, Alonso-González C, Alvarez-García V, Sánchez-Barceló EJ, Cos S.

Oncol Rep. 2010 Apr;23(4):1173-8.

PMID:
20204307
14.

Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells.

Martínez-Campa C, González A, Mediavilla MD, Alonso-González C, Alvarez-García V, Sánchez-Barceló EJ, Cos S.

Br J Cancer. 2009 Nov 3;101(9):1613-9. doi: 10.1038/sj.bjc.6605336. Epub 2009 Sep 22.

Supplemental Content

Loading ...
Support Center